Regulatory & Legal

With key partners secured, Delfin Midstream is set to greenlight America's pioneering floating LNG project, reshaping the global energy map.

With pivotal cancer drug data looming and a new nuclear supply chain, Bicycle Therapeutics is betting big on its novel platform. Will 2026 be its breakout year?

BioXcel Therapeutics is pushing its drug IGALMI® for home use, a move that could transform mental healthcare but carries significant financial and safety risks.

With a key FDA filing and pivotal data on the horizon, Pharvaris aims to redefine HAE treatment with its convenient, rapid-acting oral therapy.

IVECO and PlusAI are deploying Level 4 autonomous trucks on a key Spanish freight corridor, heralding a new era for logistics in Southern Europe.

With new funding, Nanochon is advancing its 3D-printed Chondrograft™ implant, offering hope for faster recovery to patients with chronic knee damage.

EfTEN Real Estate Fund reports its best-ever operating results, proposing an 8% dividend hike, while a minor portfolio revaluation hints at market shifts.

With booming revenue, a potential blockbuster on the horizon, and key partnerships, Ascendis Pharma lays out a bold roadmap for global dominance.

The family of a motorcyclist killed by a Tesla on Autopilot files a wrongful death suit, citing a history of deceptive marketing and known system flaws.

Facing a Nasdaq delisting notice, social commerce firm Webuy Global has 45 days to devise a plan to fix its $2.1M stockholders' equity deficiency.

Economist Jim Rickards says the U.S. is on the verge of a mineral boom, but a complex web of new rules and legal fights complicates the path forward.

In a strategic move consolidating the aviation aftermarket, AxioAero Group has acquired MRO specialist Airway Aerospace, signaling a broader industry trend.

Denver approves a $70M public investment for a new NWSL stadium, aiming to transform a vacant industrial site and cement its place in women's sports.

The Chinese auto-tech firm regained Nasdaq's minimum bid price but still faces delisting over its low market value, setting up a critical hearing.

A Minnesota law firm's call for a state investigation into a fatal ICE shooting ignites a fierce debate on state vs. federal power and accountability.

With a $30M Series A boost, Ventaris Surgical is developing a new system to solve a persistent problem in urology: incomplete kidney stone removal.

Over 3,000 Teamsters at Rush and UChicago Medical Centers demand fair pay, drawing top city officials into a high-stakes standoff with the hospitals.

After a decade of research, a promising drug for Fragile X syndrome enters a key trial, offering hope for the first-ever targeted treatment for the disorder.

A novel drug that glues cancer proteins to the cellular trash system has entered human trials, offering new hope for rare diseases like Ewing sarcoma.

CN moved record volumes of Canadian grain in 2025, fueled by a historic harvest. This article dives into the logistics, challenges, and competition.